Diagnosis of amyotrophic lateral sclerosis by respiratory function test.

amyotrophic lateral sclerosis pulmonary function test respiratory impairment

Journal

Multidisciplinary respiratory medicine
ISSN: 1828-695X
Titre abrégé: Multidiscip Respir Med
Pays: Italy
ID NLM: 101477642

Informations de publication

Date de publication:
17 Jan 2023
Historique:
received: 31 05 2023
accepted: 21 11 2023
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 7 2 2024
Statut: epublish

Résumé

The diagnostic criterion for amyotrophic lateral sclerosis (ALS) based on the findings of concomitant clinical and electrophysiological evidence of upper and lower motor neuron involvement may remain unsatisfied for months and in some patients, even for years in the early stage of the disease. Since respiratory involvement is an onset symptom of ALS in only 1-3% of patients, pulmonary assessment has never been considered useful in the early diagnosis of ALS. However, studies on pulmonary function are lacking, especially in those early stages where neurologic tests are also inconclusive. In contrast to the scarcity of data in the early stages, as the disease progresses, it is increasingly enriched by a rich set of symptoms and positive respiratory tests until respiratory failure occurs, which represents the main cause of death in ALS. Hereby we analyze the main pulmonary function tests (PFT) in the various stages of the disease, up to the recent evidence for the possibility of an early diagnosis.

Identifiants

pubmed: 38322130
doi: 10.4081/mrm.2023.941
pmc: PMC10782889
doi:

Types de publication

Journal Article

Langues

eng

Pagination

941

Informations de copyright

Copyright © 2023, the Author(s).

Auteurs

Francesca Polverino (F)

Baylor College of Medicine, Department of Medicine, Houston, TX, USA.
Lovelace Respiratory Research Institute, Albuquerque, NM, USA.

Simone Sampaolo (S)

Neurologic Division, Department of Medicine, University of Campania "L. Vanvitelli, Naples, Italy.

Antonio Capuozzo (A)

Lung Division, Department of Medicine, "M. Scarlato" Hospital, Scafati (SA), Italy.

Marco Fasolino (M)

Neurologic Division, Department of Medicine, "Umberto I" Hospital, Nocera Inferiore (SA), Italy.

Michele Aliberti (M)

LARS Rehabilitation Center, Pellezzano (SA), Italy.

Ersilia Satta (E)

Nefrocenter Research S.c.arl, Cava de' Tirreni (SA), Italy.

Carlo Santoriello (C)

Lung Division, Department of Onco-Hematology and Pneumology, AORN "Cardarelli", Naples, Italy.

Mario Polverino (M)

Lung Division, Department of Medicine, "M. Scarlato" Hospital, Scafati (SA), Italy.
Nefrocenter Research S.c.arl, Cava de' Tirreni (SA), Italy.

Classifications MeSH